首页> 美国卫生研究院文献>Public Health Action >Why are HIV-infected people not started on antiretroviral therapy? A mixed-methods study from Gujarat India
【2h】

Why are HIV-infected people not started on antiretroviral therapy? A mixed-methods study from Gujarat India

机译:为什么艾滋病毒感染者没有开始使用抗逆转录病毒疗法?来自印度古吉拉特邦的混合方法研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Setting: Five purposively selected antiretroviral therapy (ART) centres in Gujarat, India.>Objectives: To assess the proportion of ART-eligible people living with the human immunodeficiency virus (PLHIV) who were not initiated on ART within 2 months of being recorded as eligible, to identify factors associated with non-initiation and to explore reasons from the provider's perspective.>Design: We used a mixed-methods design (triangulation) of 1) a quantitative phase involving record reviews and cohort analysis (Poisson regression) of PLHIV registered during April 2014–March 2015, and 2) a qualitative phase involving one-to-one interviews with 25 providers.>Results: Of 2079 ART-eligible PLHIV, 339 (16%) were not started on ART within 2 months. PLHIV with CD4 counts of <350 cells/μl and patients who were labourers, hospitalised, bedridden or registered with certain ART centres were more likely not to be initiated on ART. Qualitative results were categorised into two broad themes: government health system- and patient-related challenges, which validated and complemented the quantitative findings.>Conclusion: Several patient subgroups at greater risk of ART non-initiation were identified, along with reasons for risk; this has important programme implications for achieving the UNAIDS 90–90–90 goal, and particularly the second 90 component of having 90% of diagnosed PLHIV start ART.
机译:>设置:位于印度古吉拉特邦的五个有目的的抗逆转录病毒疗法(ART)中心。>目标:评估符合抗逆转录病毒疗法的人类免疫缺陷病毒(PLHIV)人群的比例在被记录为合格后两个月内未启动抗逆转录病毒疗法的人员,以识别与未引发相关的因素并从提供者的角度探讨原因。>设计:我们使用了混合方法设计(三角剖分)的1)一个量化阶段,涉及2014年4月至2015年3月期间登记的艾滋病毒感染者的记录审查和队列分析(泊松回归),以及2)一个定性阶段,涉及对25名提供者的一对一访谈。>结果:< / strong>在2079个符合ART要求的PLHIV中,有339个(16%)在两个月内未开始使用ART。 CD4计数<350细胞/μl的PLHIV以及劳动者,住院患者,卧床不起的患者或在某些ART中心登记的患者更有可能不会接受ART治疗。定性结果分为两大主题:政府卫生系统挑战和与患者相关的挑战,这些挑战证实并补充了定量研究结果。>结论:确定了一些未进行抗逆转录病毒治疗的患者亚组,以及风险原因;这对于实现UNAIDS 90-90-90目标具有重要的计划意义,尤其是在90%的已诊断PLHIV患者中开始进行ART的后90个部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号